Article info
PDFDermatology
Research
Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence
- Correspondence to Dr G Lombardi; giovanni.lombardi{at}grupposandonato.it
Citation
Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence
Publication history
- Received March 16, 2016
- Revised October 10, 2016
- Accepted November 10, 2016
- First published December 9, 2016.
Online issue publication
December 09, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/